Craig D Jude
Overview
Explore the profile of Craig D Jude including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Jude C, Climer L, Xu D, Artinger E, Fisher J, Ernst P
Cell Stem Cell
. 2008 Mar;
1(3):324-37.
PMID: 18371366
The Mixed Lineage Leukemia (MLL) gene is essential for embryonic hematopoietic stem cell (HSC) development, but its role during adult hematopoiesis is unknown. Using an inducible knockout model, we demonstrate...
3.
Jude C, Gaudet J, Speck N, Ernst P
Cell Cycle
. 2008 Feb;
7(5):586-91.
PMID: 18239455
Chromosomal translocations that disrupt transcriptional regulators are frequently involved in the etiology of leukemia. To gain an understanding of the normal and pathologic roles of these transcriptional regulators, both gain-...
4.
Soper B, Duffy T, Lessard M, Jude C, Schuldt A, Vogler C, et al.
Blood Cells Mol Dis
. 2004 Feb;
32(1):199-213.
PMID: 14757436
Lysosomal storage diseases (LSD) respond to bone marrow (BM) transplantation when donor-derived cells deliver needed enzyme. Hypothetically, the ubiquitous resident macrophages (MPhi) are the primary delivery vehicle of therapeutic protein....
5.
Barker J, Schuldt A, Lessard M, Jude C, Vogler C, Soper B
Exp Hematol
. 2003 Oct;
31(11):1112-8.
PMID: 14585377
To block development of progressive childhood diseases, in utero transplantation (IUTx) requires immediate and significant donor peripheral blood (PB) cell amplification. To date, negligible and nontherapeutic donor PB cell levels...
6.
Soper B, Lessard M, Jude C, Schuldt A, Bunte R, Barker J
J Immunol
. 2003 Sep;
171(6):3270-7.
PMID: 12960357
A significant number of nonmalignant, progressive childhood disorders respond to bone marrow transplantation (BMT). Toxic myeloablative pretreatment regimens, graft failure, and graft-vs-host disease complicate the utility of BMT for neonatal...
7.
Soper B, Lessard M, Jude C, Schuldt A, Barker J
Exp Hematol
. 2002 Jul;
30(7):837-45.
PMID: 12135684
Objective: The goal of this study was to determine if competitive pressure was placed on hematopoietic stem cells (HSC) by a coinjected "carrier" population that maintains short-term survival of the...